The results of this study suggest that PBP could be a promising candidate for adjuvant therapy in pregnant women undergoing treatment with Cp, either for cancer, autoimmune diseases, nephrotic syndrome, or any other disease for which the treatment includes alkylating agents such as Cp. The gene discussed is CP; the disease is nephrotic syndrome.